›› 2014, Vol. 29 ›› Issue (7): 730-732.DOI: 10.3969/j.issn.1673-8640.2014.07.009

• Orignal Article • Previous Articles     Next Articles

Clinical significance of erythrocyte glucose-6-phosphate dehydrogenase activity detection in pathological jaundice of neonate

ZHANG Lixia1,ZOU Hongxing1,LI Yongxiang2,ZHOU Zhen2   

  1. 1. Department of Clinical Laboratory, the First Hospital of Jiaxing, Zhejiang Jiaxing 314000, China;
    2. Department of Clinical Laboratory, Jiaxing Maternity and Child Health Hospital, Zhejiang Jiaxing 314000, China
  • Received:2014-04-01 Online:2014-07-30 Published:2014-07-21

Abstract:

Objective To investigate the clinical significance of erythrocyte glucose-6-phosphate dehydrogenaseG6PDactivity detection in pathological jaundice of neonate. MethodsA total of 200 cases of neonatal pathological jaundicejaundice groupand 100 healthy newbornscontrol group were enrolled and detected for G6PD activity and the Resultswere compared. On the basis of G6PD deficiency judgment standard(<2.5 U/L), 200 cases of neonatal pathological jaundice were classified into G6PD deficiency group and non G6PD deficiency group. The comparison of bilirubin concentration and G6PD activity between the 2 groups was performed. ResultsThe concentration of bilirubin in jaundice group was significantly higher than that in control groupP0.05), but the G6PD activity in jaundice group was significantly lower than that in control groupP0.05. In G6PD deficiency group bilirubin concentration was higher than that in non G6PD deficiency groupP0.05. ConclusionsG6PD deficiency is an important cause of neonatal pathological jaundice. Strengthening the monitoring of neonatal G6PD can provide the reference for clinical prevention and treatment of neonatal pathological jaundice.

Key words: Glucose-6-phosphate dehydrogenase, Pathological jaundice, Neonate

CLC Number: